炭疽菌保护性抗原受体结合区的表达及其多克隆抗体的制备

原核表达炭疽杆菌保护性抗原受体结合区并制备该蛋白的多克隆抗体.从炭疽芽胞杆菌A16R中经PCR扩增得到了炭疽菌保护性抗原(PA)受体结合区基因,即PA的第四结构域(PA-D4),将其克隆至含有6×His编码序列的原核表达载体pET-2b(+)中,将重组质粒转化大肠杆菌BL21(DE3),在IPTG诱导下进行蛋白表达;用HiTrapTM Chelating HP柱纯化重组蛋白,Western blot进一步鉴定;以纯化后的蛋白为抗原,免疫新西兰大耳白兔制备该蛋白的多克隆抗体;用ELISA和Western blot检测抗血清.结果表明,目的蛋白在大肠杆菌BL21(DE3)中获得了可溶性表达,纯化后纯度可达90%以上;制备了针对PA-D4融合蛋白的高效价抗血清,ELISA抗体滴度为1∶ 102 400;其抗体能特异性识别内源性的PA.PA-D4重组蛋白及其多克隆抗体的获得,为后续研究其功能和炭疽疫苗免疫保护机制奠定了基础.     

沙门菌外膜蛋白D的原核表达及多克隆抗体制备

目的:在大肠杆菌中表达沙门菌外膜蛋白(OMP)D,纯化后制备兔抗OMPD抗体。方法:用PCR方法从鼠伤寒沙门菌中扩增出ompD基因,并插入融合表达载体pET-28a(+)的多克隆位点,构建重组表达质粒pET28a(+)-ompD;以重组质粒转化大肠杆菌BL21(DE3),筛选阳性重组菌株,经IPTG诱导目的蛋白表达,在变性条件下对目的蛋白进行亲和层析纯化;以表达的OMPD蛋白免疫家兔,制备抗OMPD的多克隆抗体并进行鉴定。结果:扩增了ompD基因,测序证实正确后亚克隆于表达载体pET-28a(+)中,经PCR筛选和酶切鉴定获得阳性克隆,经诱导在大肠杆菌中表达出相对分子质量为40×103的目的蛋白并进行纯化;纯化的OMPD免疫家兔后,能有效地刺激特异性抗体的产生,抗血清的效价达到1∶10000以上,且具有良好的特异性。结论:构建ompD基因的原核表达载体,并在大肠杆菌中获得高效表达;制备出兔抗OMPD抗体,效价及特异性均良好,为进一步制备肠黏膜高亲和力疫苗奠定了基础。     

人Nek2蛋白原核表达纯化及其多克隆抗体制备

目的:通过原核表达系统表达人Nek2蛋白,优化表达条件并纯化Nek2蛋白,制备抗Nek2多克隆抗体。方法:将Nek2基因片段构建到原核表达载体pET30a(+)上,转化大肠杆菌BL21(DE3);加入诱导剂IPTG诱导表达,对诱导温度、诱导剂IPTG终浓度、诱导时间等条件进行优化;利用12%SDS-PAGE后250mmol/L KCl染色切胶纯化蛋白质,将纯化后的Nek2蛋白进行质谱鉴定;纯化Nek2蛋白免疫BALB/c小鼠制备多克隆抗体,运用ELISA、Western blot和免疫荧光实验检测多克隆抗体效价和特异性。结果:构建了pET30a(+)-Nek2重组原核表达质粒,诱导的重组人Nek2蛋白主要以包涵体的形式存在;蛋白质的最适诱导表达条件为28℃,180r/min条件下加入终浓度为0. 2mmol/L IPTG诱导32h;质谱分析纯化后的蛋白质为Nek2蛋白,最终获得浓度为1. 35mg/ml纯化后的Nek2蛋白;纯化蛋白免疫小鼠,多克隆抗体效价大于1∶243 000,且具有良好的抗原特异性;免疫荧光实验显示Nek2主要定位于细胞质和细胞核。结论:利用重组人Nek2蛋白获得具有良好抗原特异性的抗Nek2多克隆抗体。     

粗糙脉孢菌ERG-11蛋白抗原的原核表达、纯化及其多克隆抗体制备

构建p ET-28a(+)-ERG-11重组质粒,表达6×His-ERG-11融合蛋白,制备ERG-11多克隆抗体。采用PCR技术扩增目的片段,插入p ET-28a(+)原核表达载体,并转入E.coli BL21(DE3)感受态表达融合蛋白,融合蛋白经亲和纯化及分子筛纯化后免疫新西兰大白兔制备多克隆抗体,取血清后,采用间接ELISA法和Western blot法检测多克隆抗体的效价及特异性。成功构建了p ET-28a(+)-ERG-11表达载体,SDS-PAGE电泳显示成功诱导出以包涵体形式存在的6×His-ERG-11融合蛋白,两步纯化后得到纯度较高的抗原,间接ELISA法显示制备的多克隆抗体效价达到1∶512 000,Western blot显示具有较高特异性。成功实现了粗超脉孢菌ERG-11蛋白的原核表达,制备出一支兔抗粗超脉孢菌ERG-11的多克隆抗体。     

人Nek2蛋白原核表达纯化及其多克隆抗体制备 *

目的通过原核表达系统表达人Nek2蛋白,优化表达条件并纯化Nek2蛋白,制备抗Nek2多克隆抗体.方法 将Nek2基因片段构建到原核表达载体pET30a(+)上,转化大肠杆菌BL21 (DE3);加入诱导剂IPTG诱导表达,对诱导温度,诱导剂IPTG终浓度,诱导时间等条件进行优化;利用12% SDS-PAGE后250mmol/L KCl染色切胶纯化蛋白质,将纯化后的Nek2蛋白进行质谱鉴定;纯化Nek2蛋白免疫BALB/c小鼠制备多克隆抗体,运用ELISA,Western blot和免疫荧光实验检测多克隆抗体效价和特异性.结果 构建了pET30a(+)-Nek2重组原核表达质粒,诱导的重组人Nek2蛋白主要以包涵体的形式存在;蛋白质的最适诱导表达条件为28℃,180r/min条件下加入终浓度为0.2mmol/L IPTG诱导32h;质谱分析纯化后的蛋白质为Nek2蛋白,最终获得浓度为1.35mg/ml纯化后的Nek2蛋白;纯化蛋白免疫小鼠,多克隆抗体效价大于1∶243 000,且具有良好的抗原特异性;免疫荧光实验显示Nek2主要定位于细胞质和细胞核.结论: 利用重组人Nek2蛋白获得具有良好抗原特异性的抗Nek2多克隆抗体.     

多胺调节因子-1原核表达与多克隆抗体制备

[目的]原核表达和纯化人多胺调节因子-1(PMF-1)并以此为抗原制备多克隆抗体。[方法]PCR扩增人PMF-1编码序列并构建原核表达质粒。将此质粒转化大肠杆菌后,IPTG诱导PMF-1蛋白表达并在变性条件下用NiNTA树脂纯化。将纯化的PMF-1用作抗原免疫大耳白兔以制备抗PMF-1多克隆抗体。ELISA法检测抗体效价,免疫印迹法和细胞免疫化学法分析抗体特异性。[结果]成功构建PMF-1原核表达质粒,在大肠杆菌中IPTG可诱导该质粒高效表达PMF-1蛋白。以纯化的PMF-1蛋白为抗原免疫大耳白兔后,获得高效价的抗PMF-1抗血清(抗体效价为1∶128 000)。该抗体能与PMF-1蛋白特异性结合,并可用于PMF-1的免疫印迹和细胞免疫化学分析。[结论]成功建立了人PMF-1原核表达和纯化技术,并制备出高特异性的抗PMF-1多克隆抗体,该抗体可用于PMF-1的免疫印迹分析和细胞免疫化学分析。     

果蝇Hsp83多克隆抗体的制备及鉴定

目的制备和鉴定抗Hsp83蛋白的多克隆抗体。方法利用PCR技术从果蝇cDNA中获得hsp83基因片段,构建重组质粒;将其转化到BL21(DE3)菌株中诱导蛋白表达,利用Ni-NTA亲和法纯化重组蛋白;再将纯化的蛋白免疫BALB/C小鼠制备多克隆抗体;利用免疫印迹法(Western blot)和免疫荧光染色法检测多克隆抗体的特异性。结果构建的pET28ahsp83质粒在大肠杆菌中成功表达了Hsp83融合蛋白,蛋白纯化后作为抗原免疫小鼠,获得了抗Hsp83的多克隆抗体。免疫印迹法和免疫荧光染色法检测显示,抗果蝇Hsp83多克隆抗体具有较高的特异性,并能检测出内源性Hsp83蛋白。果蝇卵巢免疫荧光染色显示,Hsp83蛋白定位在卵巢细胞的细胞质中。结论成功制备了小鼠抗Hsp83蛋白的特异性抗体,此工作为深入研究Hsp83蛋白的功能奠定了基础。     

Scytovirin在大肠杆菌中的可溶性表达

目的:获得Scytovirin(SVN)蛋白及其多克隆抗体.方法:按照NCBI上公布的SVN基因序列设计合成引物,合成SVN基因,构建pET32c-SVN原核表达重组质粒,经限制性酶切分析、DNA序列测定插入片段正确;将该重组质粒转化大肠杆菌BL21(DE3),IPTG诱导重组蛋白表达;用离子交换层析法及金属亲合层析法纯化蛋白,采用Tris-Tricine系统分析;以经过纯化的蛋白为抗原免疫白兔,制备SVN多克隆抗体.结果:对表达产物进行了分离纯化,SVN纯度达到91%;用纯化的样品制备了多克隆抗体,抗血清效价为1∶102 400.结论:SVN在大肠杆菌表达系统中获得了高效可溶表达,并制备了其多克隆抗体,为进一步深入研究SVN提供了材料.     

GOLPH2的原核表达、纯化、抗体制备和初步应用

目前发现GOLPH2蛋白与肝癌密切相关,将golph2基因进行克隆、表达并制备多克隆抗体,为进一步研究其功能奠定基础.应用RT-PCR技术,从人肝癌细胞系HepG2细胞中扩增得到golph2 cDNA,将其克隆到原核表达载体pET21a(+)-TRX内、转化大肠杆菌DH5a,用IPTG诱导其在大肠杆菌BL21(DE3)中表达.His-tag磁珠纯化试剂盒纯化重组蛋白GOLPH2,SDS-PAGE鉴定.将纯化的重组蛋白免疫BALB/c小鼠制备多克隆抗体,采用ELISA、Western blot方法检测抗体的灵敏度和特异性,并测定临床血清标本中GOLPH2蛋白水平.成功地构建了表达TRX-GOLPH2融合蛋白的原核表达质粒pET21a(+)-TRX-GOLPH2.并在大肠杆菌BL21(DE3)内得以高效表达,且以可溶性的形式存在.SDS-PAGE和Western blot证实,重组GOLPH2蛋白质与预期结果一致.抗血清能够特异地识别52 kD重组蛋白、73 kD细胞裂解液和血清蛋白质.成功制备了GOLPH2蛋白质和多克隆抗体,能用于后续研究.     

抗鳞翅目害虫基因cry1C的抗原表位分析及多克隆抗体制备

利用生物信息学方法预测cry1C蛋白的抗原表位区,并命名为Δcry1C。优化Δcry1C的核苷酸序列并进行人工合成,构建重组表达载体pET28b(+)-Δcry1C。在E.coli中诱导表达His6-Δcry1C蛋白,纯化后免疫新西兰大白兔,分离、纯化获得cry1C多抗血清。ELISA测定结果表明,抗体效价最高可达1∶512 000。Western Blot分析结果表明,cry1C多克隆抗体能够与cry1C转基因抗虫水稻蛋白特异性结合。利用生物信息学筛选抗原表位区并优化序列、原核表达重组蛋白、免疫制备cry1C多克隆抗体,为深入研究抗鳞翅目害虫植物提供了前提条件。     

卡他莫拉菌UspA1蛋白多克隆抗体的制备及鉴定

为制备抗卡他莫拉菌(Moraxella catarrhalis,Mc)表面蛋白UspA1胞外结构域的多克隆抗体(PcAb),对UspA1蛋白进行生物信息学分析,获取胞外结构域中抗原表位最为丰富的肽段,找到其对应的基因序列并引入大肠杆菌偏好性密码子,对其优化后化学合成全基因序列。将该基因序列按常规方法克隆入表达载体p ET-28a(+)后表达重组UspA1-His融合蛋白并纯化。以该纯化抗原免疫新西兰大白兔,经4次免疫后,用Protein A亲和层析柱从抗血清中纯化出抗UspA1-His融合蛋白PcAbIgG。经免疫荧光法、酶联免疫吸附法及Western blotting鉴定,抗UspA1-His融合蛋白PcAb能特异性识别UspA1蛋白的表面暴露区。该多抗的制备为下一步建立卡他莫拉菌快速检测技术奠定了基础。     

A new approach for producing polyclonal antibodies using impure antigens

A new convenient approach has been designed to produce polyclonal antibodies (PcAb). The approach is based on the principle of the immunoglobulin (Ig) class switch in the immune response. We produced six different antibodies (Ab) against calcineurin A subunit (CNA). CNA, His-tagged calcineurin A subunit (His-CNA), single chain calcineurin (CNB-CNA) and single chain calcineurin-calmodulin complex (CaM-CNB-CNA) were expressed in Escherichia coli (E. coli) BL21 strain, and they were used to immunize male BALB/c mice. These Ab were examined by enzyme-linked immunosorbent assay (ELISA) and western blot analysis. The results clearly demonstrated that the specificity of the Ab produced by different protein samples was much higher than that of the Ab produced by a single sample. We used CNA, CaM-CNB-CNA and His-CNA to immunize mice in turn and obtained monospecific PcAb against CNA fortunately by our new approach. Remarkably, our approach not only offered a simple and general alternative to other methods for producing PcAb described previously, but also disclosed a novel process of immunization that could be used to produce monoclonal antibodies (mAb).     

A new approach for producing polyclonal antibodies using impure antigens

A new convenient approach has been designed to produce polyclonal antibodies (PcAb). The approach is based on the principle of the immunoglobulin (Ig) class switch in the immune response. We produced six different antibodies (Ab) against calcineurin A subunit (CNA). CNA, His-tagged calcineurin A subunit (His-CNA), single chain calcineurin (CNB-CNA) and single chain calcineurin–calmodulin complex (CaM-CNB-CNA) were expressed in Escherichia coli (E. coli) BL21 strain, and they were used to immunize male BALB/c mice. These Ab were examined by enzyme-linked immunosorbent assay (ELISA) and western blot analysis. The results clearly demonstrated that the specificity of the Ab produced by different protein samples was much higher than that of the Ab produced by a single sample. We used CNA, CaM-CNB-CNA and His-CNA to immunize mice in turn and obtained monospecific PcAb against CNA fortunately by our new approach. Remarkably, our approach not only offered a simple and general alternative to other methods for producing PcAb described previously, but also disclosed a novel process of immunization that could be used to produce monoclonal antibodies (mAb).     

克隆、表达及纯化核糖体蛋白S6用于体外激酶活性检测

目的:构建40S核糖体蛋白S6的原核表达载体,表达并纯化S6蛋白,将其作为底物用于S6激酶(S6K)的体外活性测定。方法:采用RT-PCR方法从人胚肾细胞HEK293中获取S6 cDNA,将扩增产物克隆至大肠杆菌表达载体中,进行酶切及测序鉴定;IPTG诱导GST-S6融合蛋白在大肠杆菌中表达,用谷胱甘肽亲和层析纯化GST-S6,免疫沉淀法检测该蛋白是否可作为底物用于S6K的体外激酶活性测定。结果:酶切及测序鉴定表明构建了S6原核表达载体,并表达及纯化出GST-S6融合蛋白,相对分子质量为55×103。该蛋白可用于S6K的体外激酶活性测定,特异性强。结论:S6蛋白的克隆、表达与纯化成功,可用于S6K的体外激酶活性测定,为研究S6K的功能奠定了基础。     

Immunodiagnosis of Parietaria mottle virus in Tomato Crops Using a Polyclonal Antiserum against its Coat Protein Expressed in a Bacterial System

Recombinant DNA technology was used to raise a polyclonal antiserum against the coat protein (CP) of Parietaria mottle virus (PMoV). The CP gene was expressed in Escherichia coli as a fusion to a 6xHis tag and purified by affinity chromatography. Recombinant purified protein was used as antigen to raise a polyclonal antiserum. This polyclonal antiserum consistently detected PMoV specifically infected tomato plants from different commercial tomato crops by indirect enzyme-linked immunosorbent assay (I-ELISA) and direct tissue-printing immunoassay (DTBIA).     

人工合成草鱼生长激素cDNA在大肠杆菌中的表达

经密码子优化的人工合成草鱼生长激素cDNA与表达载体pET-28a( )重组,构建重组表达质粒PET－GH。转化在肠杆菌BL21（DE3）,筛选阳性克隆,IPTG诱导表达,12．5％的SDS－PAGE分析显示,大肠杆菌表达产物中含有与草鱼生长激素分子量一致的新增蛋白带,激光密度扫描,其产量约占菌体总蛋白的40％,金属离子螯合层析柱亲和纯化,获得电泳纯的重组蛋白。Western-blotting和酶联免疫吸附受体法检测证实,重组蛋白与抗草鱼生长激素的多克隆抗体发生特异性结合;复性合的重组蛋白有与天然草鱼生长激素一致的生物学活性。     

应用分子伴侣共表达系统表达pfu基因及酶活性测定

将通过In-fution方法构建的pET32a-pfu质粒与可以促进可溶性表达的HG-PGR07质粒一起转入大肠杆菌B121（DE3）共表达,以pET32a-pfu单独在B121（DE3）中表达作为对照。用热变性和（NH4）2SO4沉淀去除部分杂蛋白,再经Ni—NAT亲和层析柱纯化分离尼血蛋白,SDS-PAGE检测结果表明目的蛋白大小约为90kD,与预计的分子量大小一致。最后对其酶活性测定结果表明分子伴侣能够促进pfu基因表达,并能够提高酶活性。     

Purification and characterization of the L-Ara4N transferase protein ArnT from Salmonella typhimurium

The covalent addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) groups to lipid A, which resides in the outer membranes of bacteria such as Salmonella typhimurium and Escherichia coli, is the final step in the polymyxin-resistance pathway in these organisms. This modification is catalyzed by the inner membrane protein 4-amino-4-deoxy-L-arabinose transferase (ArnT). Little is known about the ArnT protein structure because it has not previously been purified. We report here the first expression and purification of 6 x His-tagged S. typhimurium ArnT in NovaBlue cells. The enzyme was purified using sequential Q-Sepharose anion exchange and HisLink nickel affinity column chromatography. The purified protein has an apparent molecular weight of 62 kDa on SDS-PAGE and the identity of the purified ArnT was confirmed by Western blot using a monoclonal antibody against the His-tag and by MALDI-TOF mass spectrometry. Purified ArnT protein was shown to be highly alpha-helical as determined by circular dichroism analysis. A chromosomal ArnT knockout strain of E. coli BL21(DE3) was developed to allow in vivo functional analysis of plasmid-encoded ArnT constructs, and a polymyxin assay was used to confirm that the cloned ArnT proteins retained full activity. These studies provide an essential foundation for further analysis of ArnT structure and function using mutagenesis and biophysical techniques.     

降钙素原的原核表达及单克隆抗体制备

目的:高效表达与纯化可溶性重组人PCT蛋白,制备高灵敏度和高特异性的抗人PCT医用诊断单克隆抗体。方法:大肠杆菌表达重组人PCT蛋白后,利用饱和硫酸铵沉淀和亲和层析方法纯化PCT蛋白后,经质谱、Western blot和间接ELISA法进行性质鉴定和分析重组蛋白的表达与免疫反应性;重组蛋白免疫小鼠,经细胞融合及筛选制备抗PCT单克隆抗体(m Ab)。结果:在大肠杆菌中高效表达了人PCT蛋白;重组人PCT蛋白具有良好的免疫反应性与免疫原性;经筛选获得7株抗PCT单克隆抗体细胞株,经ELISA鉴定,筛选抗体可与PCT抗原有良好的特异性反应。结论:利用重组人PCT蛋白免疫制备了抗人PCT单克隆抗体,为进一步研发PCT快速诊断试剂提供了原料。     

SIgA分泌片分离、纯化研究

为研究SIgA分泌片（Secretory component,SC)分离,纯化及鉴定方法,以SC存在游离和结合两种形式,本研究应用凝胶过滤和盐析法直接从初乳中分离纯化游离SC,并进行鉴定。分离纯化获得蛋白溶液12.4ml,蛋白含量0.85mg/ml,免疫双扩仅与抗SC多克隆抗体（PcAb)反应,分子量约75kD,免疫印迹实验与抗SC单克隆抗体（McAb)和PcAb特异反应,表明纯化蛋白为SC。该SC的分离纯化和鉴定处于不断完善之中,其方法的改进有利于获得更纯的SC,值得粘膜免疫研究者借鉴。